Fri, August 11, 2017
Thu, August 10, 2017
Wed, August 9, 2017

David Lebovitz Maintained (ALNY) at Hold with Increased Target to $50 on, Aug 10th, 2017

David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $46 to $50 on, Aug 10th, 2017.

David has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Do Kim of "BMO Capital" Initiated at Buy and Held Target at $73 on, Monday, April 17th, 2017